We rate Ipca Laboratories Ltd. a ‘BUY’. Our rating underpins the company’s
strong management, its strategy of focusing on global generic and API business and R&D activities. Company is also focusing on formulation business & therapeutic coverage especially in the fast growing lifestyle related segment.
[download id=”93″]
Leave a Reply